{"entity":{"type":"insider","cik":"0001721108","url":"/insider/0001721108","json_url":"/insider/0001721108.json","name":"Dunlop A. Sinclair","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":23,"first":"2019-12-20","last":"2025-10-15","span_basis":"filed_date"},"name_variants":[{"name":"Dunlop A. Sinclair","source":"filing","n_filings":23,"first_seen":"2019-12-20","last_seen":"2025-10-15"}],"transactions":[{"id":4426113,"accession":"0001193125-25-240563","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-240563","line_url":"/filing/0001193125-25-240563#line-3","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31092.0,"shares_display":"31,092","price_per_share":23.7211,"price_display":"23.72","price_state":"stated","total_value":737536.4412,"total_display":"737,536.44","total_whole":"737,536","shares_owned_after":3837.0,"shares_owned_after_display":"3,837","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-10","filed_date":"2025-10-15","scope":"insider"},{"id":4092953,"accession":"0001193125-25-228277","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-228277","line_url":"/filing/0001193125-25-228277#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31092.0,"shares_display":"31,092","price_per_share":22.58,"price_display":"22.58","price_state":"stated","total_value":702057.36,"total_display":"702,057.36","total_whole":"702,057","shares_owned_after":33979.0,"shares_owned_after_display":"33,979","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-02","scope":"insider"},{"id":4171057,"accession":"0001193125-25-209537","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-209537","line_url":"/filing/0001193125-25-209537#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31092.0,"shares_display":"31,092","price_per_share":22.95,"price_display":"22.95","price_state":"stated","total_value":713561.4,"total_display":"713,561.40","total_whole":"713,561","shares_owned_after":68908.0,"shares_owned_after_display":"68,908","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-19","scope":"insider"},{"id":2680079,"accession":"0000950170-24-107411","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-107411","line_url":"/filing/0000950170-24-107411","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37000.0,"shares_display":"37,000","price_per_share":36.232345945945944,"price_display":"36.23","price_state":"stated","total_value":1340596.8,"total_display":"1,340,596.80","total_whole":"1,340,597","shares_owned_after":107524.0,"shares_owned_after_display":"107,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider","n_lines":2},{"id":2343937,"accession":"0000950170-24-076423","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-076423","line_url":"/filing/0000950170-24-076423","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37000.0,"shares_display":"37,000","price_per_share":39.23878243243243,"price_display":"39.24","price_state":"stated","total_value":1451834.95,"total_display":"1,451,834.95","total_whole":"1,451,835","shares_owned_after":138693.0,"shares_owned_after_display":"138,693","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-21","filed_date":"2024-06-21","scope":"insider","n_lines":2},{"id":2514298,"accession":"0000950170-24-034277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-034277","line_url":"/filing/0000950170-24-034277#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18681.0,"shares_display":"18,681","price_per_share":57.179,"price_display":"57.18","price_state":"stated","total_value":1068160.899,"total_display":"1,068,160.90","total_whole":"1,068,161","shares_owned_after":173998.0,"shares_owned_after_display":"173,998","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-20","scope":"insider"},{"id":8530837,"accession":"0000950170-23-068183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-068183","line_url":"/filing/0000950170-23-068183#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":61.135,"price_display":"61.14","price_state":"stated","total_value":1467240.0,"total_display":"1,467,240.00","total_whole":"1,467,240","shares_owned_after":192679.0,"shares_owned_after_display":"192,679","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-05","scope":"insider"},{"id":8017310,"accession":"0001127602-23-028142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-028142","line_url":"/filing/0001127602-23-028142#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8894.0,"shares_display":"8,894","price_per_share":49.991,"price_display":"49.99","price_state":"stated","total_value":444619.954,"total_display":"444,619.95","total_whole":"444,620","shares_owned_after":122403.0,"shares_owned_after_display":"122,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-21","scope":"insider"},{"id":8598724,"accession":"0000899243-23-020450","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-020450","line_url":"/filing/0000899243-23-020450#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":49.0,"price_display":"49.00","price_state":"stated","total_value":1176000.0,"total_display":"1,176,000.00","total_whole":"1,176,000","shares_owned_after":216679.0,"shares_owned_after_display":"216,679","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-17","filed_date":"2023-11-21","scope":"insider"},{"id":8624571,"accession":"0001127602-23-012600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-012600","line_url":"/filing/0001127602-23-012600#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":74.05,"price_display":"74.05","price_state":"stated","total_value":37025.0,"total_display":"37,025.00","total_whole":"37,025","shares_owned_after":131297.0,"shares_owned_after_display":"131,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8587098,"accession":"0001127602-23-008357","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-008357","line_url":"/filing/0001127602-23-008357#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":65.33,"price_display":"65.33","price_state":"stated","total_value":32665.0,"total_display":"32,665.00","total_whole":"32,665","shares_owned_after":131797.0,"shares_owned_after_display":"131,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":8474057,"accession":"0001127602-23-003104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-003104","line_url":"/filing/0001127602-23-003104#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":52.61,"price_display":"52.61","price_state":"stated","total_value":26305.0,"total_display":"26,305.00","total_whole":"26,305","shares_owned_after":132297.0,"shares_owned_after_display":"132,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-02","scope":"insider"},{"id":8623432,"accession":"0001127602-23-001000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-001000","line_url":"/filing/0001127602-23-001000#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":50.7,"price_display":"50.70","price_state":"stated","total_value":25350.0,"total_display":"25,350.00","total_whole":"25,350","shares_owned_after":132797.0,"shares_owned_after_display":"132,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":6533790,"accession":"0000899243-22-037440","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-037440","line_url":"/filing/0000899243-22-037440#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":49.93,"price_display":"49.93","price_state":"stated","total_value":24965.0,"total_display":"24,965.00","total_whole":"24,965","shares_owned_after":129430.0,"shares_owned_after_display":"129,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-02","scope":"insider"},{"id":6691708,"accession":"0000899243-22-034916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034916","line_url":"/filing/0000899243-22-034916#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":60.83,"price_display":"60.83","price_state":"stated","total_value":30415.0,"total_display":"30,415.00","total_whole":"30,415","shares_owned_after":129930.0,"shares_owned_after_display":"129,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6153227,"accession":"0001127602-22-022205","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-022205","line_url":"/filing/0001127602-22-022205#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":975000.0,"total_display":"975,000.00","total_whole":"975,000","shares_owned_after":240679.0,"shares_owned_after_display":"240,679","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-08","scope":"insider"},{"id":6703984,"accession":"0001127602-22-020883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-020883","line_url":"/filing/0001127602-22-020883#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":65.63,"price_display":"65.63","price_state":"stated","total_value":1968900.0,"total_display":"1,968,900.00","total_whole":"1,968,900","shares_owned_after":255679.0,"shares_owned_after_display":"255,679","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-11","filed_date":"2022-08-12","scope":"insider"},{"id":6841133,"accession":"0000899243-22-024511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-024511","line_url":"/filing/0000899243-22-024511#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1341.0,"shares_display":"1,341","price_per_share":46.7881,"price_display":"46.79","price_state":"stated","total_value":62742.8421,"total_display":"62,742.84","total_whole":"62,743","shares_owned_after":1341.0,"shares_owned_after_display":"1,341","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider"},{"id":6167147,"accession":"0000899243-22-024057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-024057","line_url":"/filing/0000899243-22-024057#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":675000.0,"total_display":"675,000.00","total_whole":"675,000","shares_owned_after":285679.0,"shares_owned_after_display":"285,679","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-23","filed_date":"2022-06-24","scope":"insider"},{"id":4812331,"accession":"0000899243-21-020171","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-21-020171","line_url":"/filing/0000899243-21-020171#line-9","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5773.0,"shares_display":"5,773","price_per_share":48.1,"price_display":"48.10","price_state":"stated","total_value":277681.3,"total_display":"277,681.30","total_whole":"277,681","shares_owned_after":31855.0,"shares_owned_after_display":"31,855","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-20","filed_date":"2021-05-20","scope":"insider"},{"id":4812326,"accession":"0000899243-21-020171","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-21-020171","line_url":"/filing/0000899243-21-020171#line-8","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7612.0,"shares_display":"7,612","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":380600.0,"total_display":"380,600.00","total_whole":"380,600","shares_owned_after":300679.0,"shares_owned_after_display":"300,679","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-19","filed_date":"2021-05-20","scope":"insider"},{"id":4812321,"accession":"0000899243-21-020171","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-21-020171","line_url":"/filing/0000899243-21-020171","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149488.0,"shares_display":"149,488","price_per_share":52.84603004923472,"price_display":"52.85","price_state":"stated","total_value":7899847.34,"total_display":"7,899,847.34","total_whole":"7,899,847","shares_owned_after":110549.0,"shares_owned_after_display":"110,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-20","scope":"insider","n_lines":7},{"id":2288543,"accession":"0000899243-20-033910","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-033910","line_url":"/filing/0000899243-20-033910","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":54.6685304,"price_display":"54.67","price_state":"stated","total_value":1366713.26,"total_display":"1,366,713.26","total_whole":"1,366,713","shares_owned_after":174942.0,"shares_owned_after_display":"174,942","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-15","scope":"insider","n_lines":3},{"id":2685306,"accession":"0000899243-20-032910","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-032910","line_url":"/filing/0000899243-20-032910","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18564.0,"shares_display":"18,564","price_per_share":50.71097500538677,"price_display":"50.71","price_state":"stated","total_value":941398.54,"total_display":"941,398.54","total_whole":"941,399","shares_owned_after":199728.0,"shares_owned_after_display":"199,728","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-07","filed_date":"2020-12-07","scope":"insider","n_lines":2},{"id":2685297,"accession":"0000899243-20-032910","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-032910","line_url":"/filing/0000899243-20-032910","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6436.0,"shares_display":"6,436","price_per_share":50.25719080174021,"price_display":"50.26","price_state":"stated","total_value":323455.28,"total_display":"323,455.28","total_whole":"323,455","shares_owned_after":219676.0,"shares_owned_after_display":"219,676","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-04","filed_date":"2020-12-07","scope":"insider","n_lines":2},{"id":8346437,"accession":"0000899243-19-029783","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-029783","line_url":"/filing/0000899243-19-029783#line-4","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":29.53,"price_display":"29.53","price_state":"stated","total_value":738250.0,"total_display":"738,250.00","total_whole":"738,250","shares_owned_after":224728.0,"shares_owned_after_display":"224,728","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-20","filed_date":"2019-12-20","scope":"insider"},{"id":8346434,"accession":"0000899243-19-029783","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-029783","line_url":"/filing/0000899243-19-029783","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85110.0,"shares_display":"85,110","price_per_share":29.17940195041711,"price_display":"29.18","price_state":"stated","total_value":2483458.9,"total_display":"2,483,458.90","total_whole":"2,483,459","shares_owned_after":320681.0,"shares_owned_after_display":"320,681","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-19","filed_date":"2019-12-20","scope":"insider","n_lines":2},{"id":8346427,"accession":"0000899243-19-029783","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-029783","line_url":"/filing/0000899243-19-029783#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001721108","owner_name":"Dunlop A. Sinclair","owner_display_name":"Dunlop A. Sinclair","owner_url":"/insider/0001721108","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25890.0,"shares_display":"25,890","price_per_share":28.55,"price_display":"28.55","price_state":"stated","total_value":739159.5,"total_display":"739,159.50","total_whole":"739,160","shares_owned_after":374791.0,"shares_owned_after_display":"374,791","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":41,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Director","n_filings":23,"first_seen":"2019-12-20","last_seen":"2025-10-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001721108","retrieved_at":"2026-08-25T21:16:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}